ESR (Externally Sponsored Research) submissions may be made anytime. Only FULL and COMPLETE proposals will be reviewed. Requests will be reviewed as soon as possible; however actual review times may vary depending on numerous factors.
Externally sponsored research
Overview
Our Externally Sponsored Research (ESR) Program fosters partnerships within our community to generate evidence on our products, emphasizing our commitment to the research community and enabling better, smarter, safer healthcare.
Our ESR Program provides an avenue for Solventum to partner with non-company researchers to bring their research ideas to life. ESR studies are independently initiated, conducted and managed by a non-company researcher (e.g. individual researcher, institution, collaborative study group, cooperative group), in accordance with applicable legal, ethical, and regulatory requirements. Researchers may request support in the form of Solventum product or technology, research funding or both through our independent research path. Alternatively, if additional support for the development of a study is needed (e.g. protocol development support, statistical support), researchers can utilize our guided research path which provides access to Solventum research experts who help serve as a partner in providing technical and scientific expertise to maximize the impact and success of the trial.
PLEASE REFRAIN FROM CONTACTING A SOLVENTUM COMMERCIAL REPRESENTATIVE, AS THEY SHOULD NOT BE INVOLVED IN THE ESR PROCESS.
Please contact us directly at 3Misr@solventum.com for more detailed information about how to apply, including documentation requirements, submission guidelines and the review process.
Types of research we support
Solventum may support Externally Sponsored Research with Solventum products, as permitted under local laws and regulations, provided the research contemplated is consistent with company priorities. Research generally eligible to be considered for Solventum support includes:
Clinical Studies
A scientifically controlled study of a therapeutic agent (device or drug) where human subjects are participating.
Non-Clinical Studies/Pre-Clinical Studies
Studies which occur in the period preceding use in/on humans. These studies are in vitro, in vivo and in silico. Also includes requests for Patient Classification Methodology data.
Submission requirements
Researchers submitting to Solventum should have appropriate training and knowledge in the applicable therapeutic area; as well as appropriately trained staff and facilities to conduct the research. Researchers should also be adhering to the following guidelines:
- Good Clinical Practice (GCP);
- Good Documentation Practice (GDP);
- Good Laboratory Practice (GLP) as applicable.
Additional regulations may apply.
The following list includes the general requirements needed for submission of an initial concept to Solventum. It is recommended that the researchers review the areas below prior to submission of a concept.
All studies require the following information:
- Investigator Contact Information and CV,
- Site Contact Information,
- General Information which includes: study title, product & therapeutic area to be studied, type of support requested, and regulatory status,
- Concept Information which includes: trial design, overview/hypothesis, background/rationale, endpoints, sample size/statistical rationale, and estimated length of study
Submitted Concepts will be reviewed by Solventum. Additional Information may be requested, which may include, but is not limited to: additional scientific information (i.e. protocol), anticipated publications, detailed budget, etc. Submission of a concept does not express or imply nor guarantee approval or support.
Submit your concept
We strongly encourage you to submit your concept for review and evaluation. Your idea holds immense value to us, and we are eager to thoroughly assess its potential and explore possible opportunities for collaboration.
Frequently asked questions
Yes, a submission may still be made.
No. At this time, the system is configured for English only.
The portal system will permit users to save along the way. If there are mandatory fields, that are not complete, the submission will not be sent to Solventum. All mandatory fields must be completed prior to submission to Solventum.
Yes. Submissions may be withdrawn at any time by either the submitter or Solventum.
You will receive a contact from the Solventum ESR Coordinator within two weeks of submission to advise of additional information required and next steps/review timing.